Essilor International SA (ESLOY) Downgraded by Zacks Investment Research to Hold
According to Zacks, “Essilor International researches, develops, manufactures and markets around the world a wide range of lenses to improve and protect eyesight. It creates lenses for various types of visual disorders such as myopia, hypermetropia, presbyopia and stigmatism. The group’s know-how also covers the manufacture and sale of optical instruments mainly machines used to edge finished lenses and diagnose visual disorders. The Company sells its products through various flagship brands such as Varilux, Crizal, Essilor, Definity and Xperio. Essilor International is headquartered in Charenton-le-Pont, France. “
Shares of Essilor International SA (OTCMKTS:ESLOY) opened at 63.73 on Tuesday. The company has a market capitalization of $27.43 billion, a PE ratio of 31.39 and a beta of 0.75. Essilor International SA has a 12 month low of $57.73 and a 12 month high of $67.99. The stock’s 50 day moving average price is $64.54 and its 200 day moving average price is $64.38.
Essilor International SA Company Profile
Essilor International Compagnie Generale D’Optique SA is an ophthalmic optics company. The Company designs, manufactures and markets a range of lenses to improve and protect eyesight. It also develops and markets equipment for prescription laboratories, and instruments and services for eye care professionals.
Receive News & Stock Ratings for Essilor International SA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Essilor International SA and related stocks with our FREE daily email newsletter.